Skip, Sheba to develop treatments for rare genetic diseases
The move is expected to bypass the mutations, restore protein function, and establish effective approaches for diseases.
22 November 2023
22 November 2023
The move is expected to bypass the mutations, restore protein function, and establish effective approaches for diseases.
The one storey facility features 48-bed inpatient bedrooms, a therapy gym, and an outdoor courtyard for therapy activities.
The UPCC focuses on non-life-threatening conditions requiring attention within 12 to 24 hours.
The association commenced in 2019, when Atos was tasked with digitalising WA Health ICT systems.
The deal is expected to close in the next 60 days, subject to bankruptcy court approval and other customary conditions.
Quest will address mental health crisis in the workplace by offering in-network, virtual psychiatric care through Talkiatry.
The new features include AI orchestration, model development, visualisation, and multi-modal data management.
The IPO is subject to regulatory approvals, and if granted, trading on ADX will start in December.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Only a handful of approved therapeutic drugs are currently available for the treatment of ARF, all belonging to the solute carrier family 12 member 1 inhibitor. The clinical trial space in ARF consists of almost an equal mix of commercial as well as academic sponsors, with Iran and the US emerging as the key countries for conducting Phase III trials. While the current marketed drug space for ARF has only a handful of treatment options, currently available mid-to-late-stage pipeline drugs are likely to pave the way for a new treatment approach in the future.
Give your business an edge with our leading industry insights.